Biogen Idec (BIIB)
$197.59
0.62 (0.31%)
BIIB Stock Quote Delayed 30 Minutes
3 Highly Rated Biotech Stocks for Your July Buy List
Discover three top-rated biotech stocks that are pushing forward the pharma and biotech revolution on Wall Street.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
28.45B
PE Ratio
31.72
EPS
6.23
Volume (Avg. Vol.)
670,902
Day's Range
$196.81 - $199.78
52-Week Range
$189.44 - $269.43
Dividend & Yield
N/A (N/A)
BIIB Stock Predictions, Articles, and Biogen Idec News
BIIB Stock Earnings: Biogen Beats EPS, Misses Revenue for Q1 2024
BIIB stock results show that Biogen beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Time to Load Up on This New Magnificent 7 of ‘Strong Buy’ Stocks
Ring in the new year with these strong buy stocks that analysts love. They could form the next Magnificent 7 winners!
Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness
Discover these innovative healthcare stocks, backed by the U.S.'s $4.3 trillion health investment, offering stability and high returns.
Why Is Reata Pharmaceuticals (RETA) Stock Up 53% Today?
Reata Pharmaceuticals (RETA) stock is soaring higher on Friday as investors react to an acquisition deal with Biogen (BIIB).
Biogen Layoffs 2023: What to Know About the Latest BIIB Job Cuts
Biogen (BIIB) layoffs are on the way as the company seeks further profits with its upcoming Alzheimer's disease drug launch.
BIIB Stock Alert: What to Know as FDA Approves Biogen’s Alzheimer’s Drug
Biogen (BIIB) stock is in the news Friday after the pharmaceutical company got approval from the FDA for its Alzheimer's drug.
